{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:10:05Z","timestamp":1747887005075,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/23_021\/0008856."],"award-info":[{"award-number":["CZ.02.01.01\/00\/23_021\/0008856."]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hepatitis B (VHB) and C (VHC) are significant global public health issues, particularly for certain risk groups. In the Czech Republic, individuals who inject drugs (IDUs), incarcerated people, and those with high-risk sexual behaviours are especially susceptible. This research investigates the epidemiology, risk factors, and effects of both diseases on these groups. It analyzes the incidence of VHB and VHC in Czechia over the last twenty years in the post-vaccine era, compares their occurrence, and identifies factors influencing their rates. A total of 28,160 VHB and VHC cases reported in the Czech Republic from 2000 to 2021 were analyzed, categorized into acute and chronic forms. Specifically, there were 8,762 cases of VHB and 19,398 cases of VHC. The research employed quantitative methods and descriptive data analysis. A spatial visualization of disease occurrence per 100,000 inhabitants in Czech districts was conducted for the years 2000, 2010, and 2020 to compare disease development and the risk group of IDUs across districts. For VHB, transmission primarily occurs through intravenous drug use or risky sexual behaviour, with IDUs, men who have sex with men, and promiscuous individuals being the most at-risk groups. For VHC, sexual transmission is less common, with IDUs being the most at-risk group. Many VHC cases have been recorded in prisons, often due to shared razors or amateur tattooing and piercing. This discovery underscores the necessity for focused interventions and thorough strategies to address both diseases in high-risk communities.<\/jats:p>","DOI":"10.1186\/s12889-025-23014-6","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:14:09Z","timestamp":1747818849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of hepatitis B and C among risk groups in Czechia"],"prefix":"10.1186","volume":"25","author":[{"given":"Iva","family":"Bendlova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vojtech","family":"Simka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Ryzhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tereza","family":"Schovankova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Holy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"1","key":"23014_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12879-017-2921-8","volume":"18","author":"AA Ahmad","year":"2018","unstructured":"Ahmad AA, Falla AM, Duffell E, Noori T, Bechini A, Reintjes R, et al. Estimating the scale of chronic hepatitis B virus infection among migrants in EU\/EEA countries. BMC Infect Dis. 2018;18(1):34. https:\/\/doi.org\/10.1186\/s12879-017-2921-8.","journal-title":"BMC Infect Dis."},{"key":"23014_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.12688\/wellcomeopenres.17601.2","volume":"7","author":"R Brown","year":"2022","unstructured":"Brown R, Goulder P, Matthews PC. Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts. Wellcome Open Res. 2022;7:32. https:\/\/doi.org\/10.12688\/wellcomeopenres.17601.2.","journal-title":"Wellcome Open Res."},{"key":"23014_CR3","unstructured":"Czech Statistical Office. Number of foreigners, demographic events [Internet]. Prague; 2024 [cited 2025 Feb 27]. Available from: https:\/\/csu.gov.cz\/number-of-foreigners-demographic-events?pocet=10&start=0&podskupiny=291&razeni=-datumVydani#data-and-time-series"},{"key":"23014_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.drugpo.2019.01.012","volume":"66","author":"E Day","year":"2019","unstructured":"Day E, Broder T, Bruneau J, Cruse S, Dickie M, et al. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. Int J Drug Policy. 2019;66:87\u201393. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.012.","journal-title":"Int J Drug Policy."},{"key":"23014_CR5","unstructured":"European Centre for Disease Prevention and Control. Hepatitis B and C prevention in the EU [Internet]. Stockholm; 2022 [cited 2025 Feb 27]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/hepatitis-B-and-C-prevention-eu-december-2022.pdf"},{"issue":"1","key":"23014_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12879-017-2908-5","volume":"18","author":"AM Falla","year":"2018","unstructured":"Falla AM, Ahmad AA, Duffell E, Noori T, Veldhuijzen IK. Estimating the scale of chronic hepatitis C virus infection in the EU\/EEA: a focus on migrants from anti-HCV endemic countries. BMC Infect Dis. 2018;18(1):42. https:\/\/doi.org\/10.1186\/s12879-017-2908-5.","journal-title":"BMC Infect Dis."},{"key":"23014_CR7","unstructured":"Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"23014_CR8","unstructured":"Hejda V. Onemocn\u011bn\u00ed virem hepatitidy C. 1st ed. Prague: Schering-Plough; 2006."},{"issue":"5","key":"23014_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1086\/501771","volume":"21","author":"J Helcl","year":"2000","unstructured":"Helcl J, \u010c\u00e1stkov\u00e1 J, Bene\u0161 \u010c, Novotn\u00e1 L, Sepkowitz KA, DeHovitz JA. Control of occupational hepatitis B among healthcare workers in the Czech Republic, 1982 to 1995. Infect Control Hosp Epidemiol. 2000;21(5):343\u20136. https:\/\/doi.org\/10.1086\/501771.","journal-title":"Infect Control Hosp Epidemiol."},{"key":"23014_CR10","unstructured":"Husa P, \u0160perl J, Urb\u00e1nek P, Fra\u0148kov\u00e1 S, Pl\u00ed\u0161ek S, et al. [Diagnosis and therapy of hepatitis B virus infection: Czech national guidelines]. Klin Mikrobiol Infekc Lek. 2017;23(4):148-64. Czech."},{"issue":"3","key":"23014_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF03403814","volume":"103","author":"S Jafari","year":"2012","unstructured":"Jafari S, Buxton JA, Afshar K, Copes R, Baharlou S. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can J Public Health. 2012;103(3):207\u201312. https:\/\/doi.org\/10.1007\/BF03403814.","journal-title":"Can J Public Health."},{"issue":"Suppl 1","key":"23014_CR12","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.14309\/00000434-201110002-00357","volume":"106","author":"D Johnson","year":"2011","unstructured":"Johnson D. Hepatitis transmission risk in nail salons and barbershops and regulatory requirements for prevention: 357. Am J Gastroenterol. 2011;106(Suppl 1):S141.","journal-title":"Am J Gastroenterol."},{"key":"23014_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2022.03.018","volume":"207","author":"H Karimi-Sari","year":"2022","unstructured":"Karimi-Sari H, Rezaee-Zavareh MS. Altered hepatitis C testing and treatment beyond the COVID-19 pandemic. Public Health. 2022;207: e5. https:\/\/doi.org\/10.1016\/j.puhe.2022.03.018.","journal-title":"Public Health."},{"issue":"7","key":"23014_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ajic.2017.12.009","volume":"46","author":"M Koroglu","year":"2018","unstructured":"Koroglu M, Demiray T, Ozbek A, Guclu E, Karabay O, et al. Nail scissors and fingernails as reservoirs of hepatitis B virus DNA: role of nail scissors in household transmission of hepatitis B virus. Am J Infect Control. 2018;46(7):793\u20137. https:\/\/doi.org\/10.1016\/j.ajic.2017.12.009.","journal-title":"Am J Infect Control."},{"key":"23014_CR15","doi-asserted-by":"publisher","unstructured":"Khetsuriani N, Zaika O, Chitadze N, Slobodianyk L, Allahverdiyeva V, O'Connor P, et al. Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017. Vaccine. 2021;39(10):1485\u201392. https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.004.","DOI":"10.1016\/j.vaccine.2021.02.004"},{"key":"23014_CR16","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13828","volume":"10","author":"M Liu","year":"2022","unstructured":"Liu M, Li L, Zhao J, Ungvari GS, Ng CH, et al. Gender differences in demographic and clinical characteristics in patients with HBV-related liver diseases in China. PeerJ. 2022;10: e13828. https:\/\/doi.org\/10.7717\/peerj.13828.","journal-title":"PeerJ."},{"issue":"3","key":"23014_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/clinids\/2.3.470","volume":"2","author":"VJ McAuliffe","year":"1980","unstructured":"McAuliffe VJ, Purcell RH, Gerin JL. Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev Infect Dis. 1980;2(3):470\u201392. https:\/\/doi.org\/10.1093\/clinids\/2.3.470.","journal-title":"Rev Infect Dis."},{"issue":"5","key":"23014_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/MAT.0b013e3181b37d86","volume":"55","author":"SR Mitzner","year":"2009","unstructured":"Mitzner SR, Stange J, Klammt S, Koball S, Hickstein H, et al. Albumin dialysis MARS: knowledge from 10 years of clinical investigation. ASAIO J. 2009;55(5):498\u2013502. https:\/\/doi.org\/10.1097\/MAT.0b013e3181b37d86.","journal-title":"ASAIO J."},{"issue":"13","key":"23014_CR19","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.3390\/ijerph18137081","volume":"18","author":"TL Nguyen","year":"2021","unstructured":"Nguyen TL, Pham TH, So S, Hoang THV, Nguyen TU, Ngo TB, et al. Knowledge, attitudes and practices toward hepatitis B virus infection among students of medicine in Vietnam. Int J Environ Res Public Health. 2021;18(13):7081. https:\/\/doi.org\/10.3390\/ijerph18137081.","journal-title":"Int J Environ Res Public Health."},{"issue":"2","key":"23014_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/1010539510385220","volume":"24","author":"VT Nguyen","year":"2012","unstructured":"Nguyen VT. Hepatitis B infection in Vietnam: current issues and future challenges. Asia Pac J Public Health. 2012;24(2):361\u201373. https:\/\/doi.org\/10.1177\/1010539510385220.","journal-title":"Asia Pac J Public Health."},{"issue":"5","key":"23014_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1413-8670(10)70100-8","volume":"14","author":"AC Oliveira","year":"2010","unstructured":"Oliveira AC, Focaccia R. Survey of hepatitis B and C infection control: procedures at manicure and pedicure facilities in S\u00e3o Paulo. Brazil Braz J Infect Dis. 2010;14(5):502\u20137. https:\/\/doi.org\/10.1016\/S1413-8670(10)70100-8.","journal-title":"Brazil. Braz J Infect Dis."},{"issue":"1","key":"23014_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004275","volume":"6","author":"CM Pley","year":"2021","unstructured":"Pley CM, McNaughton AL, Matthews PC, Louren\u00e7o J. The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. BMJ Glob Health. 2021;6(1): e004275. https:\/\/doi.org\/10.1136\/bmjgh-2020-004275.","journal-title":"BMJ Glob Health."},{"issue":"6","key":"23014_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/cid\/ciac276","volume":"75","author":"P Rzymski","year":"2022","unstructured":"Rzymski P, Falfushynska H, Fal A. Vaccination of Ukrainian refugees: need for urgent action. Clin Infect Dis. 2022;75(6):1103\u20138. https:\/\/doi.org\/10.1093\/cid\/ciac276.","journal-title":"Clin Infect Dis."},{"key":"23014_CR24","unstructured":"Sl\u00e1mov\u00e1 A, Schejbalov\u00e1 M. Epidemiologie virov\u00e9 hepatitidy B se z\u0159etelem na zvl\u00e1\u0161tn\u00ed o\u010dkov\u00e1n\u00ed [Internet]. Avenier. 2016 [cited 2025 Feb 27]. Available from: https:\/\/odbornost.avenier.cz\/cz\/epidemiologie-virove-hepatitidy-b-se-zretelem-na-zvlastni-ockovani"},{"issue":"8","key":"23014_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJM198408233110803","volume":"311","author":"CE Stevens","year":"1984","unstructured":"Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med. 1984;311(8):496\u2013501. https:\/\/doi.org\/10.1056\/NEJM198408233110803.","journal-title":"N Engl J Med."},{"key":"23014_CR26","unstructured":"Str\u00e1nsk\u00fd J. Virov\u00e1 hepatitida B a jej\u00ed klinick\u00fd v\u00fdznam. Prague: Grada; 2001. ISBN 80-247-0243-6."},{"issue":"5","key":"23014_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/hep.1840010502","volume":"1","author":"W Szmuness","year":"1981","unstructured":"Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981;1(5):377\u201385. https:\/\/doi.org\/10.1002\/hep.1840010502.","journal-title":"Hepatology."},{"key":"23014_CR28","doi-asserted-by":"publisher","unstructured":"The Lancet Gastroenterology & Hepatology. Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity. Lancet Gastroenterol Hepatol. 2020;5(9):789https:\/\/doi.org\/10.1016\/S2468-1253(20)30237-5","DOI":"10.1016\/S2468-1253(20)30237-5"},{"issue":"5","key":"23014_CR29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1053\/j.ackd.2015.05.004","volume":"22","author":"E Tsipotis","year":"2015","unstructured":"Tsipotis E, Shuja A, Jaber BL. Albumin dialysis for liver failure: a systematic review. Adv Chronic Kidney Dis. 2015;22(5):382\u201390. https:\/\/doi.org\/10.1053\/j.ackd.2015.05.004.","journal-title":"Adv Chronic Kidney Dis."},{"key":"23014_CR30","unstructured":"Urb\u00e1nek P, Husa P, Pl\u00ed\u0161ek S, Ro\u017enovsk\u00fd L. [Standard diagnostic and therapeutic approach to chronic hepatitis C virus (HCV) infection 22 - guidelines]. Klin Mikrobiol Infekc Lek. 2017;23(1):22-40. Czech."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23014-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23014-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23014-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:14:14Z","timestamp":1747818854000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23014-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23014"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23014-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research utilized anonymized data from public health reporting systems and anonymized public health surveillance data, so individual patient consent was not required. The study followed the ethical guidelines for epidemiological research established by the National Institute of Public Health and complied with the General Data Protection Regulation (GDPR) for data security and confidentiality. The study protocol and data use were reviewed and approved by the institutional review board in compliance with national and institutional ethical guidelines. The reference number for this approval is SZU\/12150\/20222. The study adhered to the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1866"}}